GlassScriptPhysician profile
Harvey J Yorker
NPI 1982603080
$2,462.07
in general payments reported to CMS, 2019-2025
12 companies · $266 in 2025
The $266 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $99.38 · 2021: $211 · 2022: $602 · 2023: $232 · 2024: $815 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,313.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $505.46 | 2021-2024 | Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $251.62 | 2023-2024 | Caplyta |
| Kowa Pharmaceuticals America, INC. | $240.98 | 2022 | |
| Janssen Pharmaceuticals, INC | $235.51 | 2019 | |
| Corcept Therapeutics | $228.33 | 2024 | Korlym |
| Abbvie INC. | $208.43 | 2021-2024 | |
| Lilly USA, LLC | $200.11 | 2022-2024 | Mounjaro |
| Madrigal Pharmaceuticals | $141.23 | 2025 | Rezdiffra |
| Ani Pharmaceuticals, INC. | $125.00 | 2025 | Purified Cortrophin Gel |
| Amgen INC. | $120.29 | 2024 | Krystexxa |
| Boston Scientific Corporation | $105.73 | 2023 | Ranger |
| Allergan, INC. | $99.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Yorker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.